Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
24,203,223
-
Shares change
-
-515,426
-
Total reported value, excl. options
-
$321,208,632
-
Value change
-
-$7,502,400
-
Put/Call ratio
-
25%
-
Number of buys
-
51
-
Number of sells
-
-56
-
Price
-
$13.28
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2015
154 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2015.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,203,223 shares
of 105,632,895 outstanding shares and own 23% of the company stock.
Largest 10 shareholders include COLUMBIA WANGER ASSET MANAGEMENT LLC (3,272,400 shares), VANGUARD GROUP INC (2,423,410 shares), PERCEPTIVE ADVISORS LLC (2,204,652 shares), STATE STREET CORP (2,185,564 shares), Point72 Asset Management, L.P. (1,702,200 shares), BlackRock Fund Advisors (1,560,992 shares), FMR LLC (1,257,433 shares), BlackRock Institutional Trust Company, N.A. (1,168,899 shares), PointState Capital LP (750,000 shares), and BlackRock Advisors LLC (605,209 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.